News Focus
News Focus
Followers 41
Posts 2281
Boards Moderated 0
Alias Born 08/20/2010

Re: None

Thursday, 04/30/2026 10:50:56 PM

Thursday, April 30, 2026 10:50:56 PM

Post# of 828925
It mentions without costs to either party, but I guess a settlement still could be in there but not released, need Hoffman to chime in on X

WHEREAS, by letter dated April 30, 2026, Plaintiff Northwest Biotherapeutics, Inc.
(“NWBO”) and Defendant Canaccord Genuity LLC (“Canaccord”) have executed a settlement
agreement in which NWBO has agreed to dismiss with prejudice all claims asserted against
Canaccord in the above-captioned action, without costs to any party;
WHEREAS, NWBO and Canaccord have jointly moved by letter for dismissal of all claims
asserted against Canaccord pursuant to Federal Rule of Civil Procedure 41(a)(2);
WHEREAS, the Court finds the terms of dismissal to be proper pursuant to Federal Rule
of Civil Procedure 41(a)(2);
It is hereby ORDERED that all claims asserted against Canaccord in the above-captioned
action are dismissed with prejudice, without costs to any party.


IMO Canaccord was the weakest of all in the 208 outline.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News